Adherence with oral chemotherapy: Results from a qualitative study of the behaviour and representations of patients and oncologists

European Journal of Cancer Care

Volumn 20, Issue 4, 2011, Pages 520-527

  Regnier Denois, V ^a   Poirson, J ^a   Nourissat, A ^a   Jacquin, J P ^a   Guastalla, J P ^b   Chauvin, F ^a  

^a Institut de Cancerologie de la Loire   (France)

^b CENTRE LÉON BÉRARD   (France)

Author keywords

Adherence; Community treatment; Oral chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL;

AGED; ARTICLE; BREAST TUMOR; CLINICAL PRACTICE; CLINICAL TRIAL; COLON TUMOR; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; QUALITATIVE RESEARCH; RISK FACTOR;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COLONIC NEOPLASMS; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUALITATIVE RESEARCH; RISK FACTORS;

EID: 79958269423     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2010.01212.x     Document Type: Article

References (26)

1. Agence Nationale de Recherche sur le Sida (ANRS). L'observance aux traitements contre le VIH/sida. (2001) Collection: Sciences Sociales Et SIDA. ANRS, Paris, France.
2. Atkins L. & Fallowfield L. (2006) Intentional and non-intentional non-adherence to medication amongst breast cancer patients. European Journal of Cancer 42, 2271-2276.
3. Barron T.I., Connolly R., Bennett K., Feely J. & Kennedy M.J. (2007) Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 109, 832-839.
4. Blum J.L., Jones S.E., Buzdar A.U., LoRusso P.M., Kuter I., Vogel C., Osterwalder B., Burger HU., Brown C.S. & Griffin T. (1999) Multicenter phase II study of capecitabine in paclitaxel refractory metastatic breast cancer. Journal of Clinical Oncology 17, 485-493.
5. Cassidy J., Twelves C., Van Cutsem E., Hoff P., Bajetta E., Boyer M., Bugat R., Burger U., Garin A., Graeven U., McKendric J., Maroun J., Marshall J., Osterwalder B., Pérez-Manga G., Rosso R., Rougier P., Schilsky R.L.; Capecitabine Colorectal Cancer Study Group. (2002) First line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5 fluorouracil/leucovorin. Annals of Oncology 13, 566-575.
6. Chau I., Legge S. & Fumoleau P. (2004) The vital role of education and information in patients receiving capecitabine (Xeloda). European Journal of Oncology Nursing 8, S41-S53.
7. Chesney M.A., Morin M. & Sherr L. (2000) Adherence to HIV combination therapy. Social Science and Medicine 50, 1599-1605.
8. Escalada P. & Griffiths P. (2006) Do people with cancer comply with oral chemotherapy treatments? British Journal of Community Nursing 11, 532-536.
9. Fainzang S. (2001) Drugs and Society: the Patient, Medicines, and Prescriptions. University Press of France, Paris, France.
10. Fellowes D., Fallowfield L.J., Saunders C.M. & Houghton J. (2001) Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments? Breast Cancer Research and Treatment 66, 73-81.
11. Kidd P.S. & Parshall M.B. (2000) Getting the focus and the group: enhancing analytical rigor in focus group research. Qualitative Health Research 10, 293-308.
12. Krippendorf K. (1980) Content Analysis: An Introduction to Its Methodology. Sage Publications, Beverly Hills, CA, USA.
13. Lebovits A.H., Strain J.J., Schleifer S.J., Tanaka J.S., Bhardwaj S. & Messe M.R. (1990) Patients noncompliance with self administered chemotherapy. Cancer 65, 17-22.
14. Makoul G., Arnston P. & Schofiels T. (1995) Health promotion in primary care: physician-patient communication and decision making about prescription medications. Social Science and Medicine 41, 1241-1254.
15. Miaskowski C., Shockney L. & Chlebowski R.T. (2008) Adherence to oral endocrine therapy for breast cancer: a nursing perspective. Clinical Journal of Oncology Nursing 12, 213-221.
16. Moore S. (2007) Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nursing 30, 112-122.
17. Mullen P.D. (1997) Compliance becomes concordance. BMJ 314, 691-692.
18. Nilsson J.L., Andersson K., Bergkvist A., Björkman I., Brismar A. & Moen J. (2006) Refill adherence to repeat prescription of cancer drugs to ambulatory patients. European Journal of Cancer Care 15, 235-237.
19. O'Neill V.J. & Twelves C.J. (2002) Oral cancer treatment: developments in chemotherapy and beyond. British Journal of Cancer 87, 933-937.
20. Partridge A.H., LaFountain A., Mayer E., Taylor B.S., Winer E. & Asnis-Alibozek A. (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. Journal of Clinical Oncology 26, 556-562.
21. Partridge A.H., Wang P.S., Winer E.P. & Avorn J. (2002) Adherence to therapy with oral antineoplastic agents. Journal of the National Cancer Institute 94, 652-661.
22. Partridge A.H., Wang P.S., Winer E.P. & Avorn J. (2003) Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. Journal of Clinical Oncology 21, 602-606.
23. Reigner B., Verweij J., Dirix L., Cassidy J., Twelves C., Allman D., Weidekamm E., Roos B., Banken L., Utoh M. & Osterwalder B. (1998) Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients. Clinical Cancer Research 4, 941-948.
24. Tesch R. (1990) Qualitative Research: Analysis Types and Software Tools. Falmer Press, London, UK.
25. White H.D. (2005) Adherence and outcomes: it's more than taking the pills. Lancet 366, 1989-1991.
26. World Health Organization (2003) Adherence to long-term therapies: evidence for actions. Geneve, WHO. Available at: (accessed on 8 July 2010).